Dnmt3b’s targets in TCLs were distributed relatively equally across various genomic elements including promoters, gene bodies, enhancers, and repeats, but AF appears to be more involved in preventing hypomethylation in gene bodies (Figs. 8F and S22). This evidence concerns the gene DNMT3B and atrial fibrillation.